MedTrace Logo

Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia

NCT06176456 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-12-19

No results posted yet for this study

Summary

Evaluation effectiveness and safety of TMS in subjects with catatonia

Conditions

  • Catatonia
  • Schizophrenia
  • Schizo Affective Disorder
  • Bipolar Affective Disorder

Interventions

DIAGNOSTIC_TEST

rTMS

Active regiment

OTHER

Placebo

Tactile artefacts without magnetic pulses

Sponsors & Collaborators

  • Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-05-01
Completion
2024-11-01

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06176456 on ClinicalTrials.gov